glp 1 not obese Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Frontiers | GLP−1 receptor agonists

SGLT2 inhibitors offered more overall mortality benefits

In the CNS, ammonia is theorized to cause inflammation, oxidative injury, astrocyte swelling, increased NMDA activity, and osmotic stress which can all lead to brain injury and cerebral edema

References: Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis: Coenzyme Q10: Role of coenzyme Q10 as an antioxidant and bioenergizer in periodontal diseases: Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health: The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review: Fisetin: A Dietary Antioxidant for Health Promotion: Spermidine: a physiological autophagy inducer acting as an anti-aging vitamin in humans?: Age-Associated Changes In Oxidative Stress and NAD + Metabolism In Human Tissue:

Peptide drugs like semaglutide are notoriously difficult to deliver orally

Nanobiotechnology 16 (1), 3236

My honest opinion: the signal is strong enough to warrant formal study, and it's frustrating that the economics of peptide research make that unlikely anytime soon